Dresden, Germany

Rita Dost

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Rita Dost: Innovator in Neurology and Pharmaceuticals**

Introduction

Rita Dost, a distinguished inventor based in Dresden, Germany, has made significant contributions to the field of pharmaceuticals with a focus on neurological disorders. With a remarkable portfolio of 10 patents, her work emphasizes innovative solutions targeting the central nervous system.

Latest Patents

Among her recent patents, Rita has developed groundbreaking compounds related to pyrazole derivatives that function as NMDA NR2B receptor inhibitors. These inventions are particularly useful in treating various central nervous system diseases. Additionally, she has worked on triazoles as NR2B receptor inhibitors, providing new compounds of a specific formula that demonstrate potential for treating conditions mediated by GluN2B receptors.

Career Highlights

Throughout her career, Rita has held positions in leading pharmaceutical companies such as Janssen Pharmaceuticals, Inc. and Boehringer Ingelheim Vetmedica GmbH. Her experience in these organizations has allowed her to advance her research and patent innovations effectively.

Collaborations

Rita has collaborated with notable professionals in her field, including Hans-Joachim Lankau and Chris Rundfeldt. These partnerships have enhanced her research capabilities and contributed to her success as an inventor.

Conclusion

Rita Dost exemplifies dedication and innovation in the pharmaceutical industry. Her patents reflect her commitment to developing transformative therapies for neurological disorders, showcasing her impactful career as an inventor. Through her work, she continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…